Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase-Reference-Cited by-同舟云学术

Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase

Published:2017-09-12 Issue:43 Volume:56 Page:13184-13186
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Chellat Mathieu F.¹^ORCID,Riedl Rainer¹^ORCID

Affiliation:

1. Institute of Chemistry and Biotechnology; Center for Organic and Medicinal Chemistry; Zurich University of Applied Sciences (ZHAW); Einsiedlerstrasse 31 8820 Wädenswil Switzerland

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference12 articles.

1. http://amr-review.org 2016

2. Antibiotic resistance—the need for global solutions

3. A new antibiotic kills pathogens without detectable resistance

4. Multiple Attack on Bacteria by the New Antibiotic Teixobactin

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-Ribosylating Enzymes in the (Bio)Synthesis of C-Nucleosides and C-Glycosylated Natural Products;ACS Catalysis;2023-11-28

2. Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant Mycobacterium tuberculosis;ACS Infectious Diseases;2023-11-09

3. Drug targets, current and future therapeutics for the treatment of multi drug resistant tuberculosis with their clinical applications: A critical review;Current Drug Therapy;2023-08-30

4. An overview of mechanism and chemical inhibitors of shikimate kinase;Journal of Biomolecular Structure and Dynamics;2023-03-28

5. Structural Insights into the Role of Pseudouridimycin Binding in Disruption of Bacterial RNA Polymerase Bridge Helix Conformational Arrangement;Current Pharmaceutical Biotechnology;2023-03